Status:
COMPLETED
Anesthesia for Loop Electrosurgical Excision Procedure (LEEP).
Lead Sponsor:
Qian Wu
Conditions:
Esketamine
Loop Electrosurgical Excision
Eligibility:
FEMALE
20-60 years
Phase:
PHASE4
Brief Summary
The goal of this prospective, randomized controlled study study is to investigate the efficacy and safety of propofol combined with different doses of esketamine (ESK) for anesthesia during loop elect...
Detailed Description
To investigate the efficacy and safety of propofol combined with different doses of esketamine (ESK) for anesthesia during loop electrosurgical excision procedure (LEEP). Ninety female patients underg...
Eligibility Criteria
Inclusion
- Inclusion Criteria：
- Patients who will undergo Loop Electrosurgical Excision Procedure
- The age of the patients ranged from 20 to 60 years old
- Paients had a BMI of 18-30 kg/m2
- ASA physical status grade of I or II
- Exclusion Criteria:
- Patients who refused to participate
- History of hypertension, hyperthyroidism, or neurological or mental disorder
- Currently taking or has taken opioids and non-steroidal anti-inflammatory drugs within 48 h before surgery
- Participated in other drug clinical trials within 4 weeks
- Allergy to esketamine or propofol
- History of opioid or esketamine addiction
Exclusion
Key Trial Info
Start Date :
January 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06574945
Start Date
January 7 2022
End Date
October 28 2022
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China